Knightsbridge Asset Management, Llc
Source: SEC Form 13F · as of Mar 2026Knightsbridge Asset Management, Llc holds 18 biotech & pharma companies tracked by BioSniper, totaling $12.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$12.7M
| Company | Shares | Value |
|---|---|---|
| MCKMcKesson Corporation | 3,158 | $2.7M |
| LLYELI LILLY & Co | 1,792 | $1.6M |
| BMYBRISTOL MYERS SQUIBB CO | 16,809 | $1.0M |
| JNJJOHNSON & JOHNSON | 4,000 | $978K |
| MRKMerck & Co., Inc. | 7,463 | $898K |
| ABBVAbbVie Inc. | 4,007 | $871K |
| NVSNovartis AG | 5,383 | $822K |
| REGNREGENERON PHARMACEUTICALS, INC. | 874 | $675K |
| GMOptec International, Inc. | 7,359 | $548K |
| INCYIncyte Corp. | 4,627 | $435K |
| NBIXNEUROCRINE BIOSCIENCES INC | 3,292 | $434K |
| MEDPMedpace Holdings Inc. | 608 | $292K |
| PMPhilip Morris International Inc | 1,733 | $287K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 5,011 | $283K |
| MOHMolina Healthcare Inc | 1,962 | $262K |
| UTHRUNITED THERAPEUTICS Corp | 420 | $249K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 770 | $208K |
| SKINThe Beauty Health Company | 75,218 | $67K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.